Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Accepts healthy volunteers Results available

Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area

ClinicalTrials.gov ID: NCT01542034

Public ClinicalTrials.gov record NCT01542034. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 2:38 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of ATX-101 (Sodium Deoxycholate Injection) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To evaluate the safety and efficacy of deoxycholic acid injection in the reduction of submental fat (fat below the chin).

Study identification

NCT ID
NCT01542034
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Kythera Biopharmaceuticals
Industry
Enrollment
506 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 2012 (Type not available)
Primary completion
May 2013 (Actual)
Completion
Aug 2013 (Actual)
Last update posted
Jun 15, 2015

2012 – 2013

United States locations

U.S. sites
31
U.S. states
18
U.S. cities
27
Facility City State ZIP Site status
Investigational Site Birmingham Alabama 35205 —
Investigational Site Beverly Hills California 90210 —
Investigational Site Beverly Hills California 90212 —
Investigational Site Irvine California 92697 —
Investigational Site Los Angeles California 90201 —
Investigational Site Oceanside California 92056 —
Investigational Site San Diego California 92117 —
Investigational Site San Diego California 92121 —
Investigational Site New Haven Connecticut 06511 —
Investigational Site Washington D.C. District of Columbia 20037 —
Investigational Site Miami Beach Florida 33140 —
Investigational Site West Palm Beach Florida 33401 —
Investigational Site Atlanta Georgia 30342 —
Investigational Site Snellville Georgia 30078 —
Investigational Site Arlington Illinois 60005 —
Investigational Site Chicago Illinois 60611 —
Investigational Site Evansville Indiana 47713 —
Investigational Site Louisville Kentucky 40217 —
Investigational Site Glenn Dale Maryland 20769 —
Investigational Site Hunt Valley Maryland 21030 —
Investigational Site Rockville Maryland 20850 —
Investigational Site West Bloomfield Michigan 48322 —
Investigational Site Fridley Minnesota 55432 —
Investigational Site Omaha Nebraska 68144 —
Investigational Site New York New York 10028 —
Investigational Site New York New York 10029 —
Investigational Site Charlotte North Carolina 28207 —
Investigational Site Nashville Tennessee 37203 —
Investigational Site Nashville Tennessee 37215 —
Investigational Site Charlottesville Virginia 22911 —
Investigational Site Spokane Washington 99204 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01542034, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 15, 2015 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01542034 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →